ASSESSMENT OF THE LIFE QUALITY OF PATIENTS WITH CHRONIC PANCREATITIS COMBINED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

The article considers the aspects of quality of life of patients with isolated chronic pancreatitis (CP) and its combination with chronic obstructive pulmonary disease (COPD). The article analyzes the influence of concomitant chronic obstructive pulmonary disease on the patients' quality of life with chronic pancreatitis. The research has shown the negative impact of concomitant pathology, which is manifested by more significantly pronounced pathological changes, compared with the group of isolated chronic pancreatitis. The aim of the research: to determine the quality of life of patients with comorbid pathology and the quality of medical care (SF-36) and specialization of the respiratory (CAT) and gastroenterological (GSRS) medical questionnaires. Quality of life questionnaires are actively used to study the quality of life of patients with any medical problem. They are divided into general and specialized. Often, the use of several different types of questionnaires surcharge the patient with unnecessary paperwork and waste of time. In order to determine the feasibility of using in one patient questionnaires MOS SF-36 and CAT, we consider it necessary to conduct this analytical study. Materials and methods. 85 patients with CP and concomitant COPD were examined. The main group included 55 patients with CP and concomitant COPD. The comparison group consisted of 30 patients with CP. Clinic evaluation and health status was assessed by using the general MOS SF-36 questionnaire. We used the Russian version of the special GSRS questionnaire (Gastrointestinal Symptom Rating Scale) to assess the severity of gastroenterological symptoms and quality of life. Quality of life and respiratory symptoms were assessed by using specialized CAT questionnaire. Results. Analyzing the results of the research, it was found that concomitant COPD negatively affects the quality of life of patients with CP. A correlation analysis was performed between their scales to determine the feasibility of using three questionnaires in patients with comorbid pathology. In general, patients in both groups underestimated the general state of their health. Conclusions. Concomitant pathology, namely COPD, in patients with CP has a significant impact on quality of life, which is reflected in the analysis of indicators of both physical health and psychosocial well-being. Those features make some adjustments in the development of the disease, the effectiveness of treatment and the stage of rehabilitation in patients with comorbid pathology. This must be taken into account when selecting adequate therapeutic tactics. The influence of clinical manifestations on the subjective image of their health in patients with chronic pancreatitis and chronic obstructive pulmonary disease was manifested in the form of physical and mental warehouse of MOS SF-36 questionnaire. In contrast, the analysis of the results of the CAT questionnaire shows the clarity of the illness clinical symptoms in these patients. The related links between the MOS SF-36 and CAT questionnaires indicate that they are overlapping, what facilitates the work and practically allows one of them to be used to assess the quality of life.